LEXICON PHARMACEUTICALS INC's ticker is LXRX and the CUSIP is 528872302. A total of 113 filers reported holding LEXICON PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 1.86 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $43 | +22.9% | 39,569 | +160.9% | 0.00% | – |
Q2 2023 | $35 | +2.9% | 15,169 | +7.8% | 0.00% | – |
Q1 2023 | $34 | -26.1% | 14,069 | -42.5% | 0.00% | – |
Q4 2022 | $46 | -99.9% | 24,469 | -0.4% | 0.00% | – |
Q3 2022 | $58,000 | +28.9% | 24,576 | 0.0% | 0.00% | – |
Q2 2022 | $45,000 | +55.2% | 24,576 | +72.1% | 0.00% | – |
Q1 2022 | $29,000 | -48.2% | 14,276 | 0.0% | 0.00% | – |
Q4 2021 | $56,000 | -17.6% | 14,276 | 0.0% | 0.00% | – |
Q3 2021 | $68,000 | +4.6% | 14,276 | +0.8% | 0.00% | – |
Q2 2021 | $65,000 | -21.7% | 14,169 | 0.0% | 0.00% | – |
Q1 2021 | $83,000 | +72.9% | 14,169 | 0.0% | 0.00% | – |
Q4 2020 | $48,000 | -29.4% | 14,169 | -13.9% | 0.00% | – |
Q4 2019 | $68,000 | +38.8% | 16,461 | 0.0% | 0.00% | – |
Q3 2019 | $49,000 | -32.9% | 16,461 | +40.5% | 0.00% | – |
Q2 2019 | $73,000 | -1.4% | 11,715 | -12.2% | 0.00% | – |
Q1 2019 | $74,000 | -47.9% | 13,346 | -38.0% | 0.00% | -100.0% |
Q4 2018 | $142,000 | -51.5% | 21,518 | -21.8% | 0.00% | 0.0% |
Q3 2018 | $293,000 | -10.7% | 27,518 | +0.7% | 0.00% | -50.0% |
Q2 2018 | $328,000 | +55.5% | 27,315 | +10.5% | 0.00% | +100.0% |
Q1 2018 | $211,000 | -5.4% | 24,715 | +9.5% | 0.00% | 0.0% |
Q4 2017 | $223,000 | – | 22,580 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Ulys, L.L.C. | 4,321,214 | $25,366,000 | 100.00% |
Artal Group S.A. | 71,178,364 | $417,817,000 | 7.38% |
BVF INC/IL | 8,394,000 | $49,273,000 | 1.85% |
Boothe Investment Group, Inc. | 435,939 | $2,559,000 | 1.49% |
Campbell & CO Investment Adviser LLC | 103,100 | $605,000 | 0.37% |
NEA Management Company, LLC | 2,382,286 | $13,984,000 | 0.31% |
PINNACLE ASSOCIATES LTD | 2,167,172 | $12,721,000 | 0.24% |
Eversept Partners, LP | 410,593 | $2,410,181 | 0.18% |
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 35,714 | $210,000 | 0.12% |
OCCUDO QUANTITATIVE STRATEGIES LP | 66,299 | $389,000 | 0.08% |